Previous close | 342.46 |
Open | 341.02 |
Bid | 344.40 x 800 |
Ask | 344.94 x 1000 |
Day's range | 332.80 - 346.75 |
52-week range | 172.05 - 552.00 |
Volume | |
Avg. volume | 1,090,890 |
Market cap | 26.954B |
Beta (5Y monthly) | 1.56 |
PE ratio (TTM) | 50.90 |
EPS (TTM) | 6.78 |
Earnings date | 26 Apr 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 314.56 |
There is perhaps no better example than Align Technology (NASDAQ: ALGN). It rocketed higher after an earnings report last week that left Wall Street thinking growth is getting back on track after it boomed -- and then collapsed -- through the pandemic.
TEMPE, Ariz., February 06, 2023--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("ASR") with Citibank, N.A. ("Citi"), to repurchase $250 million of Align's common stock under Align’s $
The stock shot up around 26% after reporting fourth-quarter results that were much better than expected.